Ameritek Ventures, Inc. Annual Report for Fiscal Year Ended December 31, 2025: Key Investor Insights

Executive Summary

Ameritek Ventures, Inc. has released its Annual Report for the fiscal year ended December 31, 2025. The report provides a comprehensive overview of the company’s financial performance, operational highlights, and critical disclosures for current and prospective shareholders. This article summarizes the most important points, including those that may significantly impact share value and investor sentiment.

Key Points from the Annual Report

• Common Stock Outstanding: As of December 31, 2025, Ameritek Ventures had 9,129,000 shares of common stock outstanding, par value \$0.001.
• Company Status: Ameritek Ventures is a non-accelerated filer and a smaller reporting company, not required to provide certain disclosures typically mandated for larger entities.
• Dividends: The company has never paid cash dividends on its common stock and currently has no intention to do so. Earnings are intended to be reinvested to fund growth and development.
• Recent Sales of Unregistered Securities: No unregistered securities were sold during 2025 outside of those already reported in quarterly or current reports.
• Equity Compensation Plans: Details about equity compensation are referenced in Item 11 of Part III, indicating ongoing use of stock-based incentives.
• Liquidity & Capital Resources: Operations are funded through cash, cash equivalents, short-term investments, and financing activities. Management asserts sufficient liquidity for foreseeable needs and anticipates the possibility of issuing additional equity or debt securities if required.
• Off-Balance Sheet Arrangements: The company reports no significant off-balance sheet arrangements likely to affect financial condition or operations.
• Recent Accounting Pronouncements: No new accounting standards are expected to materially impact financial position or cash flows for the year ended December 31, 2024.
• Critical Audit Matter: The valuation and presentation of the company’s investment in ZenaTech, Inc. securities is highlighted as a critical audit matter. As of December 31, 2025, the investment was valued at \$10.47 million, with a related loss on fair-value changes of \$3.58 million for the year. The complexity of this valuation and its impact on both balance sheet and income statement make it highly relevant for investors.
• Balance Sheet Highlights:
  • Total assets at year-end 2025: \$16,207,378
  • Total liabilities: \$2,477,586
  • Stockholders’ equity: \$13,729,792
  • Retained earnings (deficit): \$11,139,635
• Income Statement Highlights:
  • Net income (loss) for 2025: (\$6,384,392) (a significant loss)
  • Net income (loss) per common share, basic and diluted: (\$1.90)
  • Weighted average number of shares outstanding: 486,022 (adjusted for a 1-for-1200 reverse stock split)
  • Stock-based compensation expense: \$477,722
  • Loss on fair value changes in investments: \$3,582,515
• Reverse Stock Split: All share and per-share data have been adjusted to reflect a 1-for-1200 reverse stock split, which could impact trading liquidity and share price dynamics.
• Major Asset Concentration: A significant portion of assets consists of investment in ZenaTech, Inc., making the company’s financial position and results highly sensitive to changes in ZenaTech’s market price and financial health.
• Cash Flow Highlights:
  • Net cash flow used in/provided by operating activities includes substantial adjustments for losses on investments and stock-based compensation.
• Audit Report: Bansal & Co., LLP served as the principal independent public accountant for the fiscal year.
• Forward-Looking Statements: The report contains forward-looking statements and cautions investors that actual results may differ materially due to risks and uncertainties.

Important Shareholder Considerations & Potential Price-Sensitive Issues

• Investment in ZenaTech, Inc.: The company’s valuation is heavily dependent on the performance and valuation of ZenaTech, Inc. Any material change in ZenaTech’s value or financial condition could substantially impact Ameritek Ventures’ share price.
• Significant Net Loss: The \$6.38 million net loss for 2025, combined with a substantial loss on fair-value changes in investments, signals financial challenges that may affect investor confidence and share price.
• Reverse Stock Split: The recent 1-for-1200 reverse stock split may affect liquidity, investor perception, and share price stability.
• No Dividends: Shareholders should not expect cash dividends in the foreseeable future, which may influence investment attractiveness for income-seeking investors.
• Equity or Debt Issuance: The company’s statement about possible future equity or debt issuance suggests potential dilution or increased leverage, depending on market conditions.
• Stock-Based Compensation: Ongoing stock-based compensation may result in further dilution of existing shareholders.
• Audit Concerns: The critical audit matter regarding ZenaTech’s securities valuation highlights risk and complexity in Ameritek Ventures’ accounting, which could affect the reliability of reported results.

Conclusion

Ameritek Ventures, Inc.’s 2025 Annual Report reveals both opportunities and significant risks for investors. The company faces challenges from a large net loss, heavy reliance on the value of ZenaTech, Inc., and potential dilution from stock-based compensation and possible future securities issuance. The recent reverse stock split and lack of dividend policy may also impact share price dynamics.

Investors should closely monitor developments related to ZenaTech, Inc., Ameritek Ventures’ liquidity and capital raising activities, and any further changes to capital structure. These factors are potentially price-sensitive and may significantly affect Ameritek Ventures’ stock valuation in the near term.

Disclaimer: This article is for informational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy or sell securities. Investors should review the full Annual Report and consult with their financial advisors before making any investment decisions. Past performance is not indicative of future results. The company’s forward-looking statements are subject to risks and uncertainties, and actual results may differ materially.

View Ameritek Ventures, Inc. Historical chart here